Plant- made biopharmaceuticals for developing countries | 5719
Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Plant- made biopharmaceuticals for developing countries

5th World Congress on Virology

December 07-09, 2015 Atlanta, USA

Kathleen Hefferon

Cornell University, USA

Posters-Accepted Abstracts: J Antivir Antiretrovir

Abstract :

Plant-produced vaccines offer enormous potential for providing relief to developing countries by reducing the incidence of infant mortality caused by infectious diseases. Vaccines derived from plants have been demonstrated to effectively elicit strong immune responses. These plant-made biopharmaceuticals are inexpensive to produce, require fewer purification steps, and can be stored at ambient temperatures for prolonged periods of time. As a result, plant-produced vaccines have the potential to be more accessible to the rural poor. This presentation will provide an overview of plant-produced biopharmaceuticals that are under development to target infectious diseases including human immunodeficiency virus, malaria and Ebola virus.

Biography :